Search - tctmd.com

Displaying 301 - 320 of 496

Sort: Relevancy | Date

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Latest Results from ABSORB Extend: Comparison with Xience

Presenter: Bernard Chevalier

October 27, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

October 15, 2013

News Daily News

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

October 15, 2013

Presentation

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

Presenter: F. Liistro

October 14, 2013

Presentation

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

Presenter: Flavio Ribichini

September 23, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

September 20, 2013

News Daily News

ISAR-LEFT MAIN 2试验：第二代DES治疗冠状动脉左主干疾病疗效相近

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

Yael L. Maxwell

September 13, 2013

News Daily News

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Yael L. Maxwell

September 13, 2013

News Conference News ESC 2013

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Yael L. Maxwell

September 02, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

对氯吡格雷产生高血小板反应性的DES患者未出现死亡风险增高

L.A. McKeown

August 12, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

可使用无创CT跟踪生物可吸收支架性能

August 08, 2013

Advertisement

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Latest Results from ABSORB Extend: Comparison with Xience

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

La Estrategia Balón liberador de Paclitaxel + SMD es Pobre comparada con los SLE en el Tratamiento de la Estenosis De Novo

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

EXECUTIVE: Xience Funciona Bien en Pacientes con Enfermedad Multivaso Menos Compleja

EXECUTIVE：依维莫司在治疗非复杂多支病变中效果良好

Elutax Paclitaxel-Eluting Balloon (PEB) Followed by BMS Compared with Xience V DES for Coronary De Novo Stenosis

A Clinical and Angiographic Study of the Xience V EES in the Treatment of Multivessel CAD

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-análisis de SPIRIT confirma superioridad total de Xience sobre Taxus

ISAR-LEFT MAIN 2试验：第二代DES治疗冠状动脉左主干疾病疗效相近

ISAR-LEFT MAIN 2 Published: Second-Generation DES Comparable in Left Main CAD

ISAR-LEFT MAIN 2 Publicado: Los SLF de 2ª Generación son Comparables en la EAC de Tronco Principal Izdo

Meta-analysis: Best Outcomes Seen with Newer-Generation DES in Women

Contemporary ZES Perform Well in Treating In-Stent Restenosis

对氯吡格雷产生高血小板反应性的DES患者未出现死亡风险增高

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

可使用无创CT跟踪生物可吸收支架性能

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content